Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Brazilian Registry of Acute SItuations in Emergency Department - BRASIED Registry

Conditions:   Acute Coronary Syndromes;   Heart Failure;   Pulmonary Edema;   Aortic Aneurysm, Familial Thoracic 1;   Chest Pain;   Pulmonary Embolism;   Syncope
Intervention:   Other: no intervention
Sponsor:   University of Sao Paulo General Hospital
Recruiting - verified April 2016

Inferior Vena Cava Retrievable Filters: Spanish Register

Condition:   Vena Cava Filters
Intervention:   Other: Inferior vena cava filter placement and retrieval
Sponsors:   Group of Research in Minimally Invasive Techniques;   SERVEI (Sociedad Española de Radiología Vascular e Intervencionista)
Not yet recruiting - verified April 2016

Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood Clots

Condition:   Deep Vein Thrombosis
Intervention:  
Sponsors:   Dr. Vicky Tagalakis;   Sanofi
Not yet recruiting - verified April 2016

Dedicated Ambulator-assisted Physical Activity to Improve Hospital Outcome Measures in Elderly Patients

Conditions:   Weakness;   Hospital Acquired Condition
Intervention:   Other: Ambulation
Sponsor:   The Cleveland Clinic
Not yet recruiting - verified April 2016

Comparison of Standard CDT vs. USAT for Patients With Acute Submassive PE

Condition:   Pulmonary Embolism
Interventions:   Procedure: CDT without ultrasound acceleration;   Procedure: CDT with ultrasound acceleration
Sponsor:   University of Pittsburgh
Not yet recruiting - verified May 2016

Low Molecular Weight Heparin for 72 Hours Followed by Dabigatran for Acute Intermediate-Risk Pulmonary Embolism.

Condition:   Pulmonary Embolism
Intervention:   Drug: Dabigatran
Sponsors:   Prof. Stavros Konstantinides, MD;   European Georges Pompidou Hospital
Recruiting - verified April 2016

RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism

Condition:   Venous Thromboembolism
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified May 2016

Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism

Conditions:   Deep Vein Thrombosis;   Malignant Neoplasm;   Portal Vein Thrombosis;   Pulmonary Embolism;   Renal Vein Thrombosis;   Venous Thromboembolism
Interventions:   Drug: Apixaban;   Drug: Dalteparin;   Other: Questionnaire Administration
Sponsors:   Academic and Community Cancer Research United;   National Cancer Institute (NCI)
Recruiting - verified April 2016

Investigation of Intravenous Tranexamic Acid With Anatomic and Reverse Total Shoulder Arthroplasty

Conditions:   Blood Loss;   Anatomic Total Shoulder Arthroplasty;   Reverse Total Shoulder Arthroplasty;   Transfusion;   Tranexamic Acid
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Rush University Medical Center
Recruiting - verified April 2016

A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department

Condition:   Pulmonary Embolism
Interventions:   Drug: Rivaroxaban;   Drug: Standard-of-care
Sponsors:   Janssen Scientific Affairs, LLC;   Bayer
Recruiting - verified April 2016

Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter System

Conditions:   Pulmonary Embolism;   Venous Thromboembolism;   Deep Vein Thrombosis
Intervention:  
Sponsor:   Volcano Corporation
Withdrawn - verified December 2015

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Condition:   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified May 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified April 2016

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)

Conditions:   Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions:   Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
Sponsor:   Bayer
Recruiting - verified April 2016

GLORIA-AF Registry Program (Phase II/III)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Active, not recruiting - verified April 2016

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified May 2016

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Intervention:  
Sponsor:   Boehringer Ingelheim
Recruiting - verified May 2016

Pulmonary Embolism Response to Fragmentation, Embolectomy, & Catheter Thrombolysis: PERFECT

Condition:   Pulmonary Embolism
Intervention:   Procedure: Catheter directed debulking of Pulmonary Embolus
Sponsors:   Stanford University;   Adventist Midwest Health;   Weill Medical College of Cornell University;   Maine Medical Center;   Memorial Hospital of South Bend;   Northside Hospital, Inc.;   Universidad de Zaragoza
Recruiting - verified April 2016